282
Views
46
CrossRef citations to date
0
Altmetric
Original

Induction of Hyaluronan Cables and Monocyte Adherence in Epidermal Keratinocytes

, , , , , & show all
Pages 115-119 | Published online: 06 Aug 2009

REFERENCES

  • de La Motte C.A., Hascall V.C., Calabro A., Yen-Lieberman B., Strong S.A. Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(I.C). J. Biol. Chem. 1999; 274: 30747–30755
  • Majors A.K., Austin R.C., de la Motte C.A., Pyeritz R.E., Hascall V.C., Kessler S.P., Sen G., Strong S.A. Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J. Biol. Chem. 2003; 278: 47223–47231
  • Selbi W., de la Motte C.A., Hascall V.C., Day A.J., Bowen T., Phillips A.O. Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int. 2006; 70: 1287–1295
  • Zhang X.L., Selbi W., de la Motte C., Hascall V., Phillips A.O. Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells. J. Am. Soc. Nephrol. 2005; 16: 79–89
  • de la Motte C.A., Hascall V.C., Drazba J., Bandyopadhyay S.K., Strong S.A. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am. J. Pathol. 2003; 163: 121–133
  • Selbi W., de la Motte C., Hascall V., Phillips A. BMP-7 modulates hyaluronan-mediated proximal tubular cell-monocyte interaction. J. Am. Soc. Nephrol. 2004; 15: 1199–1211
  • Tammi R., Ripellino J.A., Margolis R.U., Tammi M. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J. Invest. Dermatol. 1988; 90: 412–414
  • Tammi R., Pasonen-Seppänen S., Kolehmainen E., Tammi M. Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. J. Invest. Dermatol. 2005; 124: 898–905
  • Pasonen-Seppänen S., Karvinen S., Törrönen K., Hyttinen J.M., Jokela T., Lammi M.J., Tammi M.I., Tammi R. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. J. Invest. Dermatol. 2003; 120: 1038–1044
  • Saavalainen K., Pasonen-Seppänen S., Dunlop T.W., Tammi R., Tammi M.I., Carlberg C. The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. J. Biol. Chem. 2005; 280: 14636–14644
  • Karvinen S., Pasonen-Seppänen S., Hyttinen J.M., Pienimäki J.P., Törrönen K., Jokela T.A., Tammi M.I., Tammi R. Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3. J. Biol. Chem. 2003; 278: 49495–49504
  • Pienimäki J.P., Rilla K., Fulop C., Sironen R.K., Karvinen S., Pasonen S., Lammi M.J., Tammi R., Hascall V.C., Tammi M.I. Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J. Biol. Chem. 2001; 276: 20428–20435
  • Rilla K., Pasonen-Seppänen S., Rieppo J., Tammi M., Tammi R. The hyaluronan synthesis inhibitor 4-methylumbelliferone prevents keratinocyte activation and epidermal hyperproliferation induced by epidermal growth factor. J. Invest. Dermatol. 2004; 123: 708–714
  • Tammi R., MacCallum D., Hascall V.C., Pienimäki J.P., Hyttinen M., Tammi M. Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J. Biol. Chem. 1998; 273: 28878–28888
  • Baden H.P., Kubilus J. Effect of minoxidil on cultured keratinocytes. J. Invest. Dermatol. 1983; 81: 558–560
  • Hiltunen E.L., Anttila M., Kultti A., Ropponen K., Penttinen J., Yliskoski M., Kuronen A.T., Juhola M., Tammi R., Tammi M., Kosma V.M. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res. 2002; 62: 6410–6413
  • Tammi R., Ågren U.M., Tuhkanen A.L., Tammi M. Hyaluronan metabolism in skin. Prog. Histochem. Cytochem. 1994; 29: 1–81
  • Shi T., Duan Z.H., Papay R., Pluskota E., Gaivin R.J., de la Motte C.A., Plow E.F., Perez D.M. Novel alpha1-adrenergic receptor signaling pathways: secreted factors and interactions with the extracellular matrix. Mol. Pharmacol. 2006; 70: 129–142
  • Kikuchi S., Griffin C.T., Wang S.S., Bissell D.M. Role of CD44 in epithelial wound repair: migration of rat hepatic stellate cells utilizes hyaluronic acid and CD44v6. J. Biol. Chem. 2005; 280: 15398–15404
  • Jones S.G., Ito T., Phillips A.O. Regulation of proximal tubular epithelial cell CD44-mediated binding and internalisation of hyaluronan. Int. J. Biochem. Cell Biol. 2003; 35: 1361–1377
  • Lewis C.A., Townsend P.A., Isacke C.M. Ca(2+)/calmodulin-dependent protein kinase mediates the phosphorylation of CD44 required for cell migration on hyaluronan. Biochem. J. 2001; 357: 843–850
  • Bourguignon L.Y., Kalomiris E.L., Lokeshwar V.B. Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. J. Biol. Chem. 1991; 266: 11761–11765
  • Jameson J.M., Cauvi G., Sharp L.L., Witherden D.A., Havran W.L. Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J. Exp. Med. 2005; 201: 1269–1279
  • Sondergaard K., Heickendorff L., Risteli L., Risteli J., Zachariae H., Stengaard-Pedersen K., Deleuran B. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br. J. Dermatol. 1997; 136: 47–53
  • Edward M., Fitzgerald L., Thind C., Leman J., Burden A.D. Cutaneous mucinosis associated with dermatomyositis and nephrogenic fibrosing dermopathy: fibroblast hyaluronan synthesis and the effect of patient serum. Br. J. Dermatol. 2007; 156: 473–479
  • Elkayam O., Yaron I., Shirazi I., Yaron M., Caspi D. Serum levels of hyaluronic acid in patients with psoriatic arthritis. Clin. Rheumatol. 2000; 19: 455–459

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.